UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are around 8,500 people in all four corners of the globe, inspired by patients and driven by science.
If allowed, we use third party cookies to personalize content, ads and (anonymously) analyze site traffic.
Learn more